- Profit after tax
- Rs 4,728.4 mn
- EPS
- Rs 40.40 +3.1%
- EPS a year earlier
- Rs 39.18
PSX Pharmaceuticals
HALEON Haleon Pakistan Limited
Latest results: FY2025 · Dec 2025 Q2 FY2026 · Apr – Jun 2026
FY2025 revenue Rs 43.1 bn (+15.9%), profit Rs 6.4 bn (+39.2%). Dividend paid 2 years in a row.
Last close · 13 Nov 2026
Rs 697.10 ▲ 1.11 (+0.16%)
▼ 14.7% 1 year
- Market cap
- Rs 81.6 bn
- P/E
- 12.4×
- TTM to Jun 2026
- Sector 12.6×
- P/B
- 5.02×
- Quarter to Jun 2026
- Sector 3.11× · higher
- Dividend yield
- 4.3%
- FY2025
- Payers 4.7% · lower
- ROE
- 47.6%
- FY2025
- Sector 21.7% · higher
- EPS
- Rs 56.41
- TTM to Jun 2026
- Book value / share
- Rs 138.76
- Quarter to Jun 2026
Fundamentals
HALEON at a glance
Revenue · FY2025
Rs 43.1 bn
▲ 15.9% year on year
Profit attributable to shareholders · FY2025
Rs 6.4 bn
▲ 39.2% year on year
EPS – basic (Rs) · FY2025
Rs 54.45
▲ 39.2% year on year
Dividend per share (Rs) · FY2025
Rs 30.00
▲ 50.0% year on year
Net margin · FY2025
14.8%
+2.5 pts year on year
Debt to equity · FY2025
1.7%
-0.4 pts year on year
Price performance
HALEON returns
Close Rs 697.10
13 Nov 2026
| Period | Return | Rs | vs KSE-100 |
|---|---|---|---|
| MTD Month to date | +5.8% −1.1 pts vs KSE | +38.30 | −1.1 pts KSE +6.9% |
| 3M 3 months | −6.8% −5.6 pts vs KSE | −51.21 | −5.6 pts KSE −1.2% |
| 6M 6 months | −8.5% −14.8 pts vs KSE | −65.05 | −14.8 pts KSE +6.2% |
| YTD Year to date | −16.4% −18.5 pts vs KSE | −136.22 | −18.5 pts KSE +2.2% |
| 1Y 1 year | −14.7% −25.5 pts vs KSE | −120.43 | −25.5 pts KSE +10.7% |
| Long term | |||
| 3Y 3 years | +329.8% +62.6% a year +115.1 pts vs KSE | +534.89 | +115.1 pts KSE +214.7% |
| 5Y 5 years | +171.0% +22.1% a year −117.8 pts vs KSE | +439.83 | −117.8 pts KSE +288.8% |
Price return from the last close before each period; the fiscal year ends 31 December, so year to date is also fiscal year to date. Dividends are not included.
Haleon Pakistan Limited in brief
Haleon Pakistan Limited (HALEON) reported revenue of Rs 43.1 bn for FY2025 (Jan – Dec 2025), up 15.9% from FY2024.
Profit attributable to shareholders was Rs 6.4 bn (EPS Rs 54.45), up 39.2%, a net margin of 14.8%.
It declared a dividend of Rs 30.00 per share for FY2025.
The balance sheet showed net cash of Rs 7.4 bn.
Return on equity was 47.6%.
Over the last five years revenue grew at a compound 16.8% a year.
At Rs 697.10 (close on 13 Nov 2026) the shares trade at 12.4× earnings (TTM to Jun 2026) and 5.02× book value, with a dividend yield of 4.3%.
Scorecard vs Pharmaceuticals
14 companies- Growth
- Average
- 16.2%
- Profitability
- Above average
- 14.8%
- Financial health
- Above average
- 1.7%
- Valuation
- Average
- 12.4×
- Dividends
- Above average
- 4.3%
Ratings place the company in its sector: growth (3-year revenue growth), profitability (net margin; return on equity for banks, insurers and finance companies), financial health (debt to equity, industrial companies), valuation (P/E at today's price) and dividends (yield at today's price). Five dots = top fifth. Rated within the sector when at least four companies report the figure, otherwise against all PSX companies of the same type (marked vs PSX). Information, not investment advice.
Ownership
International funds holding HALEON
1 of the international funds we track lists HALEON in its latest portfolio report, shown as reported with the report's date.
- Funds holding
- 1
- Combined shares
- 417,257
- as reported
- Combined stake
- 0.36%
- of HALEON's shares
- Latest reports
- 0 added 1 reduced
- Mar 2021 – Mar 2021
| Fund | Shares | % of company | Weight in fund | Change | Report date |
|---|---|---|---|---|---|
| Matthews Emerging Asia Fund US Matthews International Capital Management LLC | 417,257 | 0.36% | 0.48% | ▼ −840,300 | Mar 2021 older report |
As reported in each fund's latest portfolio report listing HALEON; funds report on their own dates, shown on each row. These are the international funds we track, not the full foreign shareholding. Updated monthly.
Corporate
HALEON announcements & payouts
- Profit after tax
- Rs 3,201.0 mn
- EPS
- Rs 27.35 +7.8%
- EPS a year earlier
- Rs 25.38
Book closure 8 Sep – 9 Sep 2026 · Buy by Thu 3 Sep (est.) for the payout
- Profit after tax
- Rs 1,524.8 mn
- EPS
- Rs 13.03 +13.2%
- EPS a year earlier
- Rs 11.51
- Profit after tax
- Rs 6,373.2 mn
- EPS
- Rs 54.45 +39.2%
- EPS a year earlier
- Rs 39.11
Book closure 22 Apr – 28 Apr 2026 · Buy by Fri 17 Apr (est.) for the payout
Financial highlights
HALEON financial results
| Rs bn | FY2025 Jan – Dec 2025 | FY2024 Jan – Dec 2024 | FY2023 Jan – Dec 2023 | FY2022 Jan – Dec 2022 | FY2021 Jan – Dec 2021 | FY2020 Jan – Dec 2020 | FY2019 Jan – Dec 2019 | FY2018 * Jan – Dec 2018 | FY2017 Jan – Dec 2017 | FY2016 * Jan – Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 43.1 | 37.2 | 31.6 | 27.5 | 24.2 | 19.8 | 16.3 | 14.9 | 8.3 | 5.4 |
| Gross profit | 16.9 | 12.8 | 6.4 | 4.8 | 6.7 | 5.3 | 5.0 | 4.4 | 3.1 | 1.5 |
| Operating profit | 10.0 | 6.7 | 1.7 | 1.0 | 2.9 | 1.8 | 1.9 | 1.6 | 1.1 | 0.8 |
| Profit after tax | 6.4 | 4.6 | 1.0 | 0.3 | 2.1 | 1.3 | 1.3 | 1.1 | 0.7 | 0.5 |
| Profit attributable to shareholders | 6.4 | 4.6 | 1.0 | 0.3 | 2.1 | 1.3 | 1.3 | 1.1 | 0.7 | 0.5 |
| EPS – basic (Rs) Rs | 54.45 | 39.11 | 8.51 | 2.78 | 18.23 | 10.78 | 10.74 | 9.18 | 7.40 | 7.60 |
| Dividend per share (Rs) Rs | 30.00 | 20.00 | 0.00 | 0.00 | 0.00 | 5.00 | 5.00 | 5.00 | 5.00 | 0.00 |
| Total assets | 27.2 | 21.8 | 18.2 | 15.1 | 13.9 | 11.0 | 9.0 | 8.0 | 4.0 | 2.9 |
| Total equity | 14.8 | 12.0 | 8.0 | 7.0 | 6.7 | 5.2 | 4.5 | 3.8 | 2.3 | 1.6 |
| Total debt | 0.3 | 0.2 | 0.2 | 0.2 | 0.0 | 0.0 | 0.8 | 1.6 | — | — |
| Net cash from operating activities | 6.3 | 7.7 | 2.6 | 1.2 | 1.8 | 2.9 | 1.4 | (0.3) | 0.6 | 1.0 |
| Capital expenditure | (2.0) | (3.2) | (1.8) | (0.5) | (0.5) | (0.9) | (0.5) | (0.3) | (0.0) | (0.1) |
| Free cash flow (operating cash flow − capex) | 4.3 | 4.5 | 0.8 | 0.7 | 1.2 | 2.1 | 0.8 | (0.7) | 0.6 | 0.9 |
| Rs bn | TTM to Jun 2026 | Q2 FY2026 Apr – Jun 2026 | Q1 FY2026 Jan – Mar 2026 | Q4 FY2025 Oct – Dec 2025 | Q3 FY2025 Jul – Sep 2025 | Q2 FY2025 Apr – Jun 2025 | Q1 FY2025 Jan – Mar 2025 | Q4 FY2024 Oct – Dec 2024 | Q3 FY2024 Jul – Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 41.1 | 10.1 | 9.6 | 10.9 | 10.6 | 11.6 | 10.0 | 9.7 | 9.8 |
| Gross profit | 17.5 | 5.0 | 3.8 | 4.5 | 4.3 | 4.7 | 3.4 | 3.6 | 3.7 |
| Operating profit | 10.7 | 2.5 | 2.4 | 3.1 | 2.7 | 2.8 | 2.2 | 2.1 | 2.3 |
| Profit after tax | 6.6 | 1.7 | 1.5 | 1.8 | 1.6 | 1.6 | 1.3 | 1.4 | 1.3 |
| Profit attributable to shareholders | 6.6 | 1.7 | 1.5 | 1.8 | 1.6 | 1.6 | 1.3 | 1.4 | 1.3 |
| EPS – basic (Rs) Rs | 56.41 | 14.32 | 13.03 | 15.27 | 13.80 | 13.87 | 11.51 | 11.75 | 11.36 |
| Dividend per share (Rs) Rs | 30.00 | 10.00 | 0.00 | 15.00 | 5.00 | 10.00 | 0.00 | 15.00 | 5.00 |
| Total assets | 30.5 | 30.5 | 29.9 | 27.2 | 25.2 | 25.4 | 24.8 | 21.8 | 23.9 |
| Total equity | 16.2 | 16.2 | 14.6 | 14.8 | 13.6 | 13.2 | 11.6 | 12.0 | 11.2 |
| Total debt | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 |
| Net cash from operating activities | 3.9 | (0.0) | 0.3 | 3.3 | 0.3 | 1.0 | 1.7 | 2.3 | 1.8 |
| Capital expenditure | (2.3) | (0.3) | (0.4) | (1.1) | (0.4) | (0.4) | (0.1) | (1.5) | (0.6) |
| Free cash flow (operating cash flow − capex) | 1.6 | (0.4) | (0.1) | 2.2 | (0.1) | 0.6 | 1.6 | 0.7 | 1.3 |
Figures in Pakistani rupees as reported by the company; costs and cash outflows in brackets. Free cash flow and book value per share are calculated by Smart Money; TTM = the latest four quarters. Updated 17 Oct 2026.
HALEON charts
Valuation
HALEON valuation at today's price
- Price to earnings (P/E)
- 12.4×
- EPS Rs 56.41 (TTM to Jun 2026)
- Price to book (P/B)
- 5.02×
- Book value Rs 138.76 (Quarter to Jun 2026)
- Dividend yield
- 4.3%
- DPS Rs 30.00 (FY2025)
- Earnings yield
- 8.1%
- EPS ÷ price
At the closing price of Rs 697.10 on 13 Nov 2026. P/E and P/B are not shown when earnings or book value are negative.
Sector peers
HALEON vs Pharmaceuticals companies
| Company | Market cap | P/E | P/B | Yield | ROE | 3-yr growth |
|---|---|---|---|---|---|---|
| HALEON | Rs 81.6 bn | 12.4× | 5.02× | 4.3% | 47.6% | 16.2% |
| GLAXO | Rs 107.1 bn | 10.3× | 3.11× | 5.1% | 32.4% | 16.3% |
| ABOT | Rs 97.9 bn | 11.4× | 3.05× | 4.0% | 28.8% | 15.2% |
| HINOON | Rs 50.8 bn | 12.8× | 3.95× | 5.2% | 32.3% | 20.5% |
| AGP | Rs 43.8 bn | 11.7× | 2.92× | 5.1% | 25.9% | 26.0% |
| HPL | Rs 38.5 bn | 10.3× | 4.50× | 6.0% | 38.6% | 18.6% |
| FEROZ | Rs 15.8 bn | 16.1× | 1.19× | 1.5% | 7.6% | 27.9% |
| CPHL | Rs 14.5 bn | 18.3× | 1.34× | 0.0% | 7.3% | 4.3% |
| MACTER | Rs 12.0 bn | 17.7× | 2.87× | 0.0% | 17.4% | 20.7% |
Compare
Compare HALEON with
Analyses & signals 0
Win rate — · 0 closed signals · average return —
No analyses published for HALEON yet.
HALEON: frequently asked questions
What is HALEON's EPS?
Haleon Pakistan Limited reported basic earnings per share of Rs 54.45 for FY2025 (Jan – Dec 2025). Over the trailing twelve months (TTM to Jun 2026) EPS was Rs 56.41.
What is HALEON's P/E ratio?
At the closing price of Rs 697.10 on 13 Nov 2026, HALEON trades at a P/E of 12.4× based on EPS of Rs 56.41 (TTM to Jun 2026).
Does HALEON pay dividends?
Yes. Haleon Pakistan Limited declared a dividend of Rs 30.00 per share for FY2025. It has paid a dividend in each of the last 2 years. At Rs 697.10 that is a dividend yield of 4.3%.
What was HALEON's revenue and profit in FY2025?
Haleon Pakistan Limited reported revenue of Rs 43.1 bn and profit attributable to shareholders of Rs 6.4 bn for FY2025 (Jan – Dec 2025).
What is HALEON's book value per share?
Haleon Pakistan Limited's book value per share was Rs 126.41 at the end of FY2025. The shares trade at 5.02× book value.
How has HALEON's share price performed?
HALEON's share price is down 16.4% year to date (KSE-100: +2.2%), down 14.7% over one year (KSE-100: +10.7%) and up 171.0% over five years (KSE-100: +288.8%), as of 13 Nov 2026. These are price returns; dividends are not included.
Information only, not investment advice.